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Abstract
 Human mast cells (MCs) are long-lived tissue-resident immuneBackground:
cells characterised by granules containing the proteases chymase and/or
tryptase. Their phenotype is modulated by their tissue microenvironment. The
human uterus has an outer muscular layer (the myometrium) surrounding the
endometrium, both of which play an important role in supporting a pregnancy.
The endometrium is a sex steroid target tissue consisting of epithelial cells
(luminal, glandular) surrounded by a multicellular stroma, with the latter
containing an extensive vascular compartment as well as fluctuating
populations of immune cells that play an important role in regulating tissue
function. The role of MCs in the human uterus is poorly understood with little
known about their regulation or the impact of steroids on their differentiation
status.
The current study had two aims: 1) To investigate the spatial and temporal
location of uterine MCs and determine their phenotype; 2) To determine
whether MCs express receptors for steroids implicated in uterine function,
including oestrogen (ERα, ERβ), progesterone (PR) and glucocorticoids (GR).
 Tissue samples from women (n=46) were used for RNA extraction orMethods:
fixed for immunohistochemistry.
 Messenger RNAs encoded by   (tryptase) and Results: TPSAB1 CMA1
(chymase) were detected in endometrial tissue homogenates.
Immunohistochemistry revealed the relative abundance of tryptase MCs was
myometrium>basal endometrium>functional endometrium. We show for the
first time that uterine MCs are predominantly of the classical MC subtypes:
(positive, +; negative, -) tryptase+/chymase- and tryptase+/chymase+, but a
third subtype was also identified (tryptase-/chymase+). Tryptase+ MCs were of
an ERβ+/ERα-/PR-/GR+ phenotype mirroring other uterine immune cell
populations, including natural killer cells.
 Endometrial tissue resident immune MCs have threeConclusions:
protease-specific phenotypes. Expression of both ERβ and GR in MCs mirrors
that of other immune cells in the endometrium and suggests that MC function
may be altered by the local steroid microenvironment.
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Introduction
Mast cells (MCs) are long-lived tissue resident immune cells, 
derived from CD34+/c-kit+ pluripotent progenitors, that reside in 
the bone marrow (Kirshenbaum et al., 1999). MC progenitors are 
recruited into peripheral tissues by chemokines secreted by stro-
mal cells, which together with stem cell factor, a complex array of 
cytokines, and a range of micro-environmental factors, are reported 
to stimulate the development of tissue resident mature MCs 
(Valent et al., 1992). Mature MCs are usually classified according 
to the presence of one or more serine proteases (tryptase and/or 
chymase) in prominent cytoplasmic granules.
MCs are typically phenotyped as MCTC, with granules containing 
both tryptase and chymase, or MCT, with granules only contain-
ing tryptase alone (Collington et al., 2011; Wernersson & Pejler, 
2014). It has been reported that MCs maturing in different tissue 
microenvironments can vary widely in the amount of tryptase 
and chymase they contain (Caughey, 2007). When MCs are acti-
vated they de-granulate by exocytosis, releasing these serine pro-
teases together with other inflammatory meditators (Lorentz et al., 
2012; Tiwari et al., 2008). The female sex hormones, oestradiol 
and progesterone, are thought to have an impact on MCs because 
many pathophysiological conditions attributed to MC activity 
have a higher prevalence in females than males (Narita et al., 
2007). Studies in non-reproductive tissue systems and those using 
the HMC-1 cell line (human MC line, (Butterfield et al., 1988)) 
have reported that MCs express the oestrogen receptor α iso-
form (ERα) and progesterone receptor (PR) (Jensen et al., 2010; 
Nicovani & Rudolph, 2002; Zaitsu et al., 2007). Some authors 
found evidence that MCs can be rapidly stimulated to degranu-
late by oestradiol via ERα (Zaitsu et al., 2007). Glucocorticoid 
treatments are reported to reduce the number of tissue resident 
MCs by reducing concentrations of stem cell factor that are 
required for MC survival (Finotto et al., 1997). Glucocorticoids are 
also reported to prevent MC activation via their high-affinity IgE 
receptor (Smith et al., 2002).
The human endometrium undergoes physiological cycles of 
cellular proliferation, differentiation and secretory activity during 
each menstrual cycle (Johannisson et al., 1987). In the absence of 
embryo implantation, the upper functional layer of the endometrium 
breaks down and is shed at menstruation, which is consid-
ered to bear the hallmarks of an inflammatory process (Jabbour 
et al., 2006). Endometrial tissue adjacent to the myometrium 
(basal compartment) is not shed during menstruation and is 
implicated in the rapid re-epithelialisation, cessation of bleeding 
and restoration of tissue homeostasis facilitating regeneration of 
the functional layer. This monthly tissue remodelling is regulated 
by changes in cyclical ovarian steroid hormones with oestrogen 
increasing cell proliferation, progesterone inducing functional 
maturation of stromal cells in preparation for implantation, and 
progesterone withdrawal precipitating a cascade of changes 
culminating in tissue breakdown and menstruation (Kelly et al., 
2001; Maybin & Critchley, 2015; Salamonsen & Lathbury, 2000). 
Endometrial tissue contains stromal, epithelial, and endothelial 
cells, as well as a diverse population of immune cells, the most 
abundant of which are uterine natural killer cells (uNK) and mac-
rophages (Evans & Salamonsen, 2012; Thiruchelvam et al., 2013). 
We, and others, have investigated the impact of steroids on 
uNK cells and macrophages and shown that they contain both 
receptors that can bind oestrogens (ERβ isoform) and glucocor-
ticoids (Bombail et al., 2008; Henderson et al., 2003), but are 
immmuno-negative for ERα and PR. The concentrations of steroids 
in endometrial tissue are subject to local modulation by enzymes 
that metabolise sex steroids (androgens, oestrogens), as well 
as glucocorticoids (Bamberger et al., 2001; Gibson et al., 2013; 
Gibson et al., 2016; McDonald et al., 2006). The creation of a 
steroid rich microenvironment has an impact on the function of 
immune cells and the vasculature. For example, exposure of uNK 
to oestrogens increases their secretion of CCL2, which has an 
impact on vascular endothelial cells (Gibson et al., 2015), and 
likewise exposure of macrophages to cortisol results in the 
release of factors that induce altered endometrial endothelial cell 
expression of angiogenic genes (Thiruchelvam et al., 2016).
The basal portion of the endometrium sits directly on the myo-
metrium, which is made up of three layers consisting of smooth 
muscle fibres and associated vasculature and stroma. The inner 
layer, adjacent to the endometrium, is also known as the junctional 
zone. This zone has circular muscle fibres and like the endometrium 
it is derived from the Mullerian duct (Uduwela et al., 2000), 
whilst the other layers develop from non-Mullerian tissue. 
The smooth muscle cells of the myometrium (myocytes) are 
active during the non-pregnant menstrual cycle, with uterine peri-
stalsis constituting one of their fundamental functions (Kunz & 
Leyendecker, 2002). Like the endometrium, the myometrium 
is a steroid target organ with myocytes expressing receptors for 
oestrogens, progestagens and androgens, all of which can induce 
changes in gene expression (Chandran et al., 2016; Makieva et al., 
2016).
MCs have been identified in the human uterus, with reports that 
their phenotype is similar to lung MCs in terms of a response 
to secretagogues and release of prostaglandins, but a granule 
phenotype distinct to that of gut MCs (Massey et al., 1991). 
There has also been interest in the role played by MCs in myo-
metrial contractions and in fibroids, although whether they play 
an important role in either has been questioned (Garfield et al., 
2006; Menzies et al., 2011; Protic et al., 2016). A detailed study 
on uterine MCs was published by Jeziorska et al. (1995), who 
used immunohistochemistry to identify tryptase and chymase posi-
tive cells in 107 uterine samples taken across the menstrual cycle. 
They reported that there were similar MC numbers throughout the 
functional, basal layers of the endometrium, and myometrium dur-
ing the menstrual cycle.
In summary, the role of MCs in the human uterus is poorly under-
stood and little is known about their regulation, or the impact of 
steroids within the uterine microenvironment on their differentia-
tion status. The current study used tissue sections of human uterus to 
define the spatial and temporal location of MCs in the myometrium 
and endometrium, and explored their phenotype by examining the 
pattern of expression of the proteases tryptase and chymase using 
fluorescent co-staining. We also examined expression receptors for 
oestrogen (ERα, ERβ), progesterone (PR) or glucocorticoids (GR) 
to determine their ability to respond directly to steroids.
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Methods
Patients and tissue recovery
Ethical committee approval was obtained from the Lothian 
Research Ethics Committee (LREC; approval numbers, 
10/S1402/59 and 16/ES/0007). Patients were recruited by dedi-
cated research nurses from clinics treating women for benign 
gynaecological conditions, including heavy menstrual bleeding 
and fibroids. In all cases written patient consent was obtained 
prior to tissue collection. Full details of patients are provided in 
Supplementary Table 1. Patients were aged between 25–50 
years (average of 39.8 years), reported regular menstrual cycles 
and had not taken any exogenous hormones in the three months 
prior to surgery. Stage of the menstrual cycle was evaluated by 
analysis of circulating steroid concentrations (P4, E2) using blood 
samples obtained at the time of surgery. Assays were performed 
by the Specialist Assay Service (Surf Facility, University of 
Edinburgh) and cycle stage was further confirmed by examina-
tion of tissue sections by an expert pathologist, Professor A.R.W. 
Williams (NHS, Royal Infirmary, Edinburgh). Critical inclusion 
criteria were the absence of pelvic pain, such as dysmenorrhea, 
absence of fibroids or presence of small fibroids only (<3 cm). 
Samples from a total of n=46 women were used in the course of 
this study.
RNA extraction, cDNA synthesis and qRT-PCR
Total RNA was extracted using the RNeasy Mini Kit (Qiagen, 
UK), according to manufacturer’s instructions. RNA concen-
tration and purity was measured using the Nanodrop (LabTech 
International, UK) and standardised to 100ng/µl for all samples. 
Reverse transcription was performed using 100ng of RNA with 
0.125× Superscript Enzyme in 1× VILO reaction mix (Thermo 
Fisher Scientific, UK) at 25°C for 10 minutes, followed by 42°C 
for 60 minutes and finally 85°C for 5 minutes. Quantitative PCR 
was performed using FAM labelled probes for TPSAB1 (number 
20) and CMA1 (number 81) from the Universal Probe Library 
(Roche Diagnostics, UK) and VIC labelled human PPIA (Cyclo-
philin A) endogenous control (Thermo Fisher Scientific), with 
specific primers for TPSAB1 (forward 5’-cctgcctcagagacct-
tcc-3’; reverse 5’-acctgcttcagaggaaatgg-3’) and CMA1 (forward 
5’-ttcacccgaatctcccatta-3’; reverse 5’-tcaggatccaggattaatttgc-3’) 
(Eurofins Genomics, UK). Primers directed against human cyclo-
phillin A (CYC, PPIA) served as an endogenous control were sup-
plied in a premade kit purchased from Thermo Fisher Scientific 
(catalogue number 4310883E). Each 15µl reaction consisted 
of 1µl of cDNA in 1× Express qPCR Supermix (Thermo Fisher 
Scientific) with 200nM of forward and reverse primer, 100nM 
probe, amplified for 40 cycles at 95°C for 15s followed by 60°C 
for 1 minute using the ABI Prism 7900HT Fast Real-Time 
PCR System (Applied Biosystems, UK). Analysis was by 
relative standard curve using tonsil mRNA (ASD-0088; Applied 
StemCell, USA), a positive control for mRNA expression of 
MC proteases (Irani et al., 1986).
Statistical analysis was carried out using GraphPad Prism 6.0 
(GraphPad Software, USA). Data are presented as the median. 
One-way ANOVA was used, and Kruskal-Wallis was performed as 
a secondary test with Dunn’s multiple comparisons test. Criterion 
for significance was p<0.05.
Phenotyping mast cells by immunohistochemistry and dual 
colour immunofluorescence
Immunohistochemistry was carried out on “full thickness” (uter-
ine lumen to endometrial-myometrial junction) human uterine 
sections to localize MCs to the different tissue layers: myometrium, 
basal endometrium and functional (luminal) endometrium. 
Uterine biopsies were fixed in 4% neutral buffered formalin, 
embedded in paraffin wax and cut to 5µm sections. Following 
dewaxing and rehydration, sections were blocked in methanol 
peroxide for 30 minutes on a rocker at room temperature (RT), 
followed by 30 minutes blocking in normal goat blocking serum 
(Sigma Aldrich, Dorset, UK), before primary antibody incuba-
tion at 4°C overnight: Tryptase, rabbit monoclonal, Abcam, UK; 
Chymase, mouse monoclonal, AbSerotec, UK; ERα, mouse 
monoclonal, Vector Laboratories, UK; ERβ mouse monoclonal, 
AbSerotec, UK. After washing in 1× Tris Buffered Saline + 
0.05% Tween, slides were incubated with secondary antibody 
for 1 hour at RT, followed by 1:50 tyramide signal amplification 
(TSA Fluorescein Tyramide Reagent Pack, PerkinElmer, USA) 
for 10 minutes. Antigen retrieval was performed at pH6 in cit-
rate buffer, and then further blocked with serum to avoid cross- 
reactivity. The second primary antibody was then added and 
incubated overnight at 4°C. Incubation with an appropriate sec-
ondary antibody at 4°C for 16 hours and a further TSA amplifi-
cation step were carried out before counterstaining the sections 
with DAPI (1:500 dilution in TBS) and mounting with permafluor 
(ThermoFisher Scientific). Fluorescent images were acquired 
with a Zeiss Axioscan Z1 or a Zeiss 710 confocal microscope, and 
analysed with Zen Blue or Black software (version 2; Zeiss, Jena, 
Germany). Full antibody details can be found in Supplementary 
Table 2.
Results
Messenger RNAs encoding mast cell proteases were 
detected in human endometrium
In tissue homogenates of endometrium, total concentrations of 
messenger RNAs encoded by TPSAB1 (gene for tryptase α and 
βisoforms; Figure 1A) and CMA1 (chymase; Figure 1B) did not 
change significantly (TPSAB1 0.254; CMA1 0.867), according to 
stage of the menstrual cycle. 
Immunoflourescence identified three distinct mast cell 
subtypes in uterine biopsies collected during different stages 
of the menstrual cycle
Immunoexpression of both tryptase and chymase positive cells 
were identified in all three layers of the human uterus examined 
in this study. In line with a previous report (Jeziorska et al., 1995), 
the numbers of tryptase immunopositive cells appeared higher 
in the myometrium and adjacent basal layer of the endometrium 
than in the functional layer (green cells) in all phases of 
the cycle (Figure 2 and Figure 3, Supplementary Figure 1– 
Supplementary Figure 3). Notably some of the chymase cells 
(red staining) in the myometrium appeared to be ‘activated’, with 
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Figure 1. Messenger RNAs encoded by genes encoding mast cell proteases were not cycle stage dependent. (A) TPSAB1 mRNA and 
(B) CMA1 mRNA. Single dots represent different patient samples, and data are expressed as the median. Proliferative phase n=14, early 
secretory phase n=7, mid secretory phase n=6, and menstrual phase n=3.
Figure 2. Comparison of immunoexpression of chymase and tryptase in “full thickness” (uterine lumen to endometrial/myometrial 
junction) tissue samples obtained from across the menstrual cycle. Note that mast cells were less abundant in the functional layer and 
appeared to be exclusively tryptase+/chymase-. (A–C) Functional, basal endometrium and myometrium during proliferative phase (P); (D–F) 
Early secretory phase (ES); (G–I) Mid secretory phase (MS); (J–L) Late Secretory phase (LS); (M–O) Menstrual phase (M); (P–R) Negative 
control (omission of primary antibody). Double immunofluorescence has revealed the presence of three uterine mast cell subtypes, single 
tryptase, single chymase and double tryptase-chymase positive cells. (P n=4, ES n=4, MS n=2, LS n=3, M n=2): negative controls were 
included on all sections.
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immunopositive staining being intense and diffuse within the 
tissue during both the early (Supplementary Figure 2) mid 
(Figure 3, arrow) and late (Supplementary Figure 3) secretory and 
menstrual (Figure 4, arrows) phases.
Examination of tissues from 20 of the patients obtained at differ-
ent stages of the cycle, including the proliferative (Supplementary 
Figure 1), early (Supplementary Figure 2) mid (Figure 3) 
and late (Supplementary Figure 3) secretory and menstrual 
(Figure 4) phases, also identified a population of MCs that 
were chymase positive, but without co-incident expression of 
tryptase (arrows). These cells appeared less abundant than those 
that were immunopositive for both tryptase and chymase (arrow-
heads), and were confined to the basal compartment of the 
endometrium and the myometrium.
The data obtained from immunohistochemical analysis of the 
20 patients are summarized in Table 1.
Tryptase-positive uterine mast cells were immunopositive for 
oestrogen receptor beta but did not express either oestrogen 
receptor alpha or progesterone receptor.
The uterus is an oestrogen target organ and detailed immunohis-
tochemical studies conducted on menstrual cycle staged sections 
of endometrial tissue by ourselves (Bombail et al., 2008; 
Critchley et al., 2001) and others (Mylonas et al., 2004; Snijders 
et al., 1992) have documented cell and phase-dependent expres-
sion of both isoforms of the oestrogen receptor (ERα, ERβ). In the 
current study, in line with expectation, we identified ERα 
positive stromal and epithelial cells in the endometrium and stro-
mal fibroblasts in the myometrium (Supplementary Figure 4); 
however, although tryptase-positive cells were readily detected in 
the basal endometrium and myometrium, none of these had detect-
able ERα protein in their nuclei (Supplementary Figure 4). In 
contrast, immunopositive staining for ERβ protein was present in 
multiple cell types, including stromal fibroblasts and endometrial 
epithelial cells, as well as tryptase-positive (green cytoplasm) MCs 
Figure 3. A population of chymase positive mast cells that did not express tryptase was identified in uterine tissue samples from the 
mid secretory phase. The endometrial compartment shows three different mast cell (MC) subtypes: tryptase single positive, chymase single 
positive and tryptase and chymase double positive. Basal endometrial MCs are chymase+/tryptase- single positive and double positive, 
instead functional endometrium MCs are fewer in number and show a chymase-/tryptase+ phenotype. MCs during the secretory appeared 
to be activated in the myometrium, releasing both proteases from the cytoplasm. (n=3) (Arrowheads: MCTC cells; Vs: MCT cells; arrows: MCC 
cells).
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Figure 4. Samples from the menstrual phase contained chymase positive cells that appeared to be ‘activated’, as well as abundant 
double positive cells in the basal endometrium. Uterine mast cells (MCs) appear to be tryptase and chymase double positive, in both 
myometrial and basal endometrial layers, with a small portion of chymase+ MCs in the myometrium. MCs were not detectable in the functional 
layer. MCs during the menstrual phase appeared to be activated only in myometrial compartment, releasing both tryptase and chymase from 
the cytoplasm. In the basal endometrium, MCs showed a steady state instead. (n=2) (Arrowheads: MCTC cells; Vs: MCT cells; arrows: MCC 
cells).
Table 1. Summary of uterine mast cell phenotypes documented in tissue samples 
collected across the menstrual cycle.
Proliferative Early 
secretory
Mid 
secretory
Late 
secretory Menstrual
Mast cell 
sub-types
Endo MCT, MCTC MCT, MCTC
MCT, MCTC, 
MCC
MCT MCTC
Myo MCTC, MCC
MCT, MCTC, 
MCC
MCT, MCTC MCTC MCTC, MCC
in both the functional and basal regions of the endometrium and 
throughout the myometrium of the uterus (Figure 5, arrows). The 
results obtained with antibody directed against the progesterone 
receptor mirrored those of ERα, with no evidence of PR-positive 
MCs (Supplementary Figure 5).
Uterine mast cells are immunopositive for the glucocorticoid 
receptor.
We have previously identified GR in multiple cells within the 
endometrium, including endothelial cells and immune cells 
(Rae et al., 2009; Thiruchelvam et al., 2016), complemented by 
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Figure 5. Mast cells are immunopositive for ERβ. Immunohistochemistry showed co-localization of ERβ in uterine mast cells (MCs). Nuclear 
expression of ERβ receptor (red staining) was detected in MCs across the tissue structures of uterus, myometrium, basal and functional 
endometrium, and during both the proliferative and secretory phases of the menstrual cycle. (Proliferative n=5, Secretory n=5).
evidence that enzymes capable of the biosynthesis of cortisol, 
the natural ligand for GR, are present in the tissue (Thiruchelvam 
et al., 2016). In the present study, immunostaining for GR 
showed it was expressed within the stromal fibroblasts and 
other cells (putative immune cells), as well as being present in 
the nucleus of tryptase-positive cells in both endometrium and 
myometrium (arrowheads, Figure 6).
In summary, we detected co-immunoexpression of both the beta 
isoform of ER and GR in the nuclei of uterine MCs (tryptase 
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Figure 6. Uterine mast cells in the endometrium and myometrium are immunopositive for glucocorticoid receptor. Mast cell nuclear 
glucocorticoid receptors (GR; red staining) was detected during the proliferative and secretory phase, throughout the myometrium, functional 
and basal endometrial and layers. The images are representative of results in proliferative (n=5) and secretory (n=5) phase samples.
positive staining in their cytoplasm), but no evidence of immu-
noexpression of ERα or PR. A photomontage of representative 
sections stained for each of the receptors is provided in Figure 7.
Dataset 1. TPSAB1 and CMA1 CT values for qRT-PCR
http://dx.doi.org/10.5256/f1000research.11432.d160468
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Figure 7. Summary immunoexpression of steroid receptors in human uterine mast cells. Uterine mast cells are immunopositive for ERβ 
and GR, and immunonegative for ERα and PR. (Red staining: ERα, ERβ, PR and GR; green staining: tryptase). Arrowheads point to nuclei 
that have immunopositive (red) staining for ERβ and GR.
Discussion
This study has shed new light both on the phenotype of endome-
trial and myometrial MCs, as well as revealing the potential that 
they might respond in situ to both oestrogens and glucocorticoids. 
MCs are known to arise from progenitors in the bone marrow, 
but adapt to their mature phenotype depending upon the tissue 
microenvironment in which they mature. To date, uterine MCs 
have received little attention compared to other immune cell 
populations, such as uNK cells and macrophages (Gibson et al., 
2015; Henderson et al., 2003; Thiruchelvam et al., 2013). For 
example, detailed analysis of immune cell populations in 
endometrium show cyclical variations in their numbers of immune 
cells, with a notable rise in uNK cells during the secretory phase, 
a rise in numbers of neutrophils at the start of menstrual tissue 
breakdown and the largest numbers of macrophages detected 
during the menstrual phase (reviewed in Maybin & Critchley, 
2015).
Analysis of mRNAs encoding proteases expressed by MCs has 
not previously been reported in endometrial tissue homoge-
nates. We found that the concentrations of tryptase and chymase 
mRNAs in our samples did not vary significantly between different 
phases of the menstrual cycle. These results would be consist-
ent with previous reports that MC numbers vary little throughout 
the menstrual cycle (Salamonsen et al., 2002). We speculate that 
these results may reflect the long life span of tissue resident MCs, 
with some studies reporting that MCs have a lifespan of weeks 
to months (Kiernan, 1979; Padawer, 1974). As tryptase and chy-
mase are constitutively expressed by MCs (Pejler et al., 2007), it is 
unsurprising they may remain unchanged if cell numbers are 
fairly constant.
Traditionally, human MCs are classified according to differ-
ent phenotypes depending on their expression of tryptase and/or 
chymase in cellular granules (Irani et al., 1986). In line with expec-
tations based on MC phenotype in multiple tissues, we readily 
detected both tryptase positive and chymase positive cells within 
both the endometrium and myometrium. Using immunofluores-
cence, we were able to co-stain for tryptase and chymase in the 
same cells revealing populations of cells that were of MCT and 
MCTC phenotypes. Weidner & Austin (1993) were the first to 
report the existence of a chymase positive/tryptase negative (MCC) 
population of MCs in skin, lung and bowel. MCC have been 
detected by immunofluorescence in the airway and gastrointesti-
nal tract, reported as being 12% of the MC population in human 
bronchi and 16.8% bowel submucosa. The current study provides 
the first evidence for the presence of a chymase positive subpopu-
lation of MCs that did not contain tryptase. This complements 
and extends a previous study that stained parallel tissue sections 
with antibodies directed against tryptase and chymase (Jeziorska 
et al., 1995), identifying both MCT and MCTC, and increases both 
our understanding of the location and phenotypic heterogeneity of 
MCs in the uterus.
Results in this study showed the phenotype of the uterine MCs 
varied between the different tissue layers of the uterus. Confirm-
ing previous studies, MCTC were predominantly resident in the 
basal endometrium and in the myometrium and MCT were found 
in functional endometrium. The rare MCC type was detected in 
the basal endometrium and myometrium and completely absent 
in the functional layer. These findings reinforce the principle 
that tissue specific phenotypes of MCs can exist within different 
regions within the same organ. It is already well known that the 
functional and basal compartments of the endometrium and myo-
metrium vary with regard to cellular composition and cytokine/
chemokine concentrations. Interestingly the region of the tissue 
where MCs appeared most abundant were close to the endome-
trial-myometrial junction. Previous studies have demonstrated that 
a large number of CD34+ MC progenitor cells reside in this area of 
the tissue and that their numbers are independent of phase of the 
menstrual cycle (Cho et al., 2004; Mai et al., 2008). Finding MCs 
in close proximity to smooth muscle fibres would be consistent with 
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this cell type being a key source of stem cell factor, and a vital 
mediator for MC maturation and survival (Zhang et al., 1996).
The activation state of uterine MCs was also explored during 
the present study. Previously, endometrial MCs were reported to 
degranulate during the secretory phase, at a time when the tissue 
is in an oedematous state. This observation was based on detec-
tion of extracellular tryptase during oedema and weak intracel-
lular tryptase staining detectable during the proliferative phase 
(Jeziorska et al., 1995). In this study, endometrial activation 
and the degranulation of MCs was documented during the early 
and mid-secretory stages of normal uterine tissue with detection of 
tryptase and chymase in the extracellular matrix. A ‘recovery’ state, 
characterised by weak immunostaining, was observed in tissue 
collected from patients during the proliferative (Supplementary 
Figure 1), late secretory (Supplementary Figure 3) and menstrual 
(Figure 4) stages. Within the myometrial compartment, MCs 
appeared to be in a ‘resting’ state during the proliferative phase 
(Supplementary Figure 1). Interestingly, in the myometrium, MCs 
appeared to be ‘activated’ with detection of immunopositive stain-
ing for chymase diffuse and spread beyond the margins of the 
individual cells during both mid secretory and menstrual phases 
(Figure 3 and Figure 4). We speculate that this might suggest a 
potential role for MC derived proteases in regulation of arteriole 
sprouting at early/mid secretory phases. A previous study also 
suggested the release of granules may play a role in smooth 
muscle contraction during menses (Sivridis et al., 2001) and our 
findings would be consistent with this suggestion.
Although, other authors have previously demonstrated a direct effect 
of female sex hormones on MC behaviour, activation and migra-
tion, in those studies they cited activation of MCs via ERα and PR 
(Jensen et al., 2010; Zaitsu et al., 2007). In this study, based on 
detailed immunohistochemical analysis, using previously validated 
antibodies directed against oestrogen receptor subtypes (Critchley 
et al., 2002; Henderson et al., 2003), we found novel evidence for 
immunoexpression of ERβ, but no evidence of expression of ERα. 
These results mirror the oestrogen receptor phenotype of both uNK 
(Gibson et al., 2015; Henderson et al., 2003)) and macrophages 
(Thiruchelvam et al., 2013). This observation is also supported by 
the activation of uterine MCs during the secretory phase at a time 
in the menstrual cycle when intracrine biosynthesis of oestradiol 
has been shown to activate ERβ positive uNKs (Gibson et al., 
2015).
In other studies, we have shown that in endometrial tissue 
expression of ERβ often parallels that of GR with co-expression 
in both uNK (Henderson et al., 2003) and endothelial cells 
(Critchley et al., 2002). In the current study, nuclear GR was 
detected in MCs in the functional, basal endometrium and myo-
metrium. In the same samples, GR protein was also detected 
in endometrial stroma and smooth muscle fibres during the 
proliferative phase, but its expression was reduced during the 
progesterone-dominant secretory phase, a result which was 
in agreement with previous reports (Bamberger et al., 2001; 
Henderson et al., 2003). Several studies have reported that 
glucocorticoids may have an indirect anti-inflammatory impact 
on MCs, with the postulated mechanism being a reduction of 
stem cell factor production by fibroblasts (Da Silva et al., 2002). 
Alternatively, they may also have direct impacts by reducing 
IgE binding to the FcεRI receptors, thereby down regulating the 
expression of these receptors on the cell membrane of the MCs 
and inhibiting MC degranulation in vitro (Finotto et al., 1997; 
Yamaguchi et al., 2001; Zhou et al., 2008). Prior to the current 
study, the only report of expression of GR in human MCs was 
from Oppong et al. (2014). In their study, they localized GR to the 
plasma membrane in the RBL-2H3 MC line. The current study 
is the first to demonstrate that uterine MCs are immunopositive 
for nuclear GR. A glucocorticoid rich environment would favour 
activation of GR, with shuttling of ligand activated receptor 
from the cytoplasm towards the nucleus (Phuc Le et al., 2005). 
This observation would be consistent with expression 11-β 
hydroxysteroid dehydrogenase enzymes within the uterus, result-
ing in a cortisol rich microenvironment (Gibson et al., 2013; 
McDonald et al., 2006).
In summary, our study confirms that MCs are members of the 
leukocyte population of the human uterus, and that they are most 
abundant in the myometrial and basal endometrial compart-
ments. Whilst uterine MCs predominantly belong to the classic 
MC subtypes: tryptase positive/chymase negative (MCT) and tryp-
tase/chymase positive (MCTC), a rare third subtype (MCC) was 
also identified in the uterus for the first time. We demonstrated 
that endometrial and myometrial MCs are immunopositive for 
both ERβ and GR, demonstrating that, like other immune cells 
present in the endometrium (uNK, macrophages), they may 
be a target for the direct actions of oestrogens and glucocorti-
coids, which are both synthesised within the endometrial tissue 
microenvironment. This study provides a framework for fur-
ture studies on the role of MCs in endometrial and myometrial 
disorders, including conditions associated with increased pain, such 
as endometriosis.
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Supplementary Table 1. Details of patients, cycle stage, diagnosis and use of individual samples in different experimental protocols.
Click here to access the data.
Supplementary Table 2. Details of antibodies used for immunofluorescence.
Click here to access the data.
Supplementary Figure 1. Immunolocalisation of tryptase and chymase in proliferative phase endometrium. Single fluorescence 
channels show the different mast cell subtypes in a uterine “full thickness” section during proliferative phase of the menstrual cycle. The 
myometrial compartment shows three different mast cell subtypes: tryptase single positive, chymase single positive and tryptase and chy-
mase double positive. Basal endometrial mast cells are tryptase single positive and double positive, instead functional endometrium MCs 
are fewer in number and show a tryptase only phenotype. The MC activation profile during proliferative phase looks quiescent; proteases are 
retained in the cytoplasm. (n=4) (White triangles: MCTC cells; white Vs: MCT cells; white arrows: MCC cells).
Click here to access the data.
Supplementary Figure 2. Mast cell subtypes and activation state during the early secretory phase. Single fluorescence channels show 
the different mast cell subtypes in a uterine full thickness section during the early secretory phase. Myometrial compartment shows three 
different mast cell subtypes: tryptase single positive, chymase single positive and tryptase and chymase double positive. Basal endometrial 
mast cells are tryptase single positive and double positive, instead functional endometrium MCs are fewer in number and show a chymase 
negative phenotype. MCs during the early secretory phase appeared to be activated, releasing both proteases from the cytoplasm. (n=4) 
(White triangles: MCTC cells; white Vs: MCT cells; white arrows: MCC cells).
Click here to access the data.
Supplementary Figure 3. Mast cell subtypes and activation state during the late secretory phase. During the late secretory phase, MCs 
are identified as tryptase single positive and weakly double positive (MCTC). In both the endometrial layers MCs showed a strong tryptase 
only phenotype. MCs during the late secretory phase appeared to be activated only in the myometrial compartment, releasing tryptase and 
retaining chymase in the cytoplasm. (n=3) (White triangles: MCTC cells; white Vs: MCT cells).
Click here to access the data.
Supplementary Figure 4. Immunoexpression of ERalpha (ERα) was detected in multiple cell types within the endometrium 
and myometrium but not in the nuclei of tryptase-positive mast cells (MCs). Double immunofluorescence showed no ERα immunoex-
pression (red staining) in the nuclei of uterine MCs (green staining). MCs were noted to be immunonegative in all uterine layers and across 
the phases of the menstrual cycle. Myometrial, stromal andepithelial cells showed expression for ERα, as expected (Proliferative n=5, 
Secretory n=5).
Click here to access the data.
Supplementary Figure 5. Mast cells and progesterone receptor (PR) immunoexpression in the human uterus. Mast cells were dem-
onstrated to be immunonegative for PR expression (red staining), across “full thickness” uterine sections and during both the proliferative 
and secretory phase. (Proliferative n=5, Secretory n=5).
Click here to access the data.
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reference to the more widely known method.
 
In dual IHC, was the 2RT antibody incubation for 16h? This appears to be relatively longer than the
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In dual IHC, was the 2RT antibody incubation for 16h? This appears to be relatively longer than the
usual protocols. Did the authors use a quantification method to assess the immunolocalisation of
the proteins of interest?
 
Results:
The total number of samples mentioned in the Methods is 46, yet there is inconsistent numbers
used at different aspects of the analysis. Particularly in the paragraph describing steroid receptors
co-stained with tryptase, the number of samples stated in the legends of referenced figures does
not add up to 20 as mentioned in the text.
 
The authors present data on the steroid receptor expression in tryptase-positive uterine mast cells
why did they not present the data for the same in the chymase-positive cells? It is noticeable that
not all the MC were ERβ+, this might be associated with chymase expression?
 
Data in Table 1 could be more informative, with quantification of the expression and statement if
this refers to the exact endometrial layer; basalis or functionalis.
 
In Figure 6, GR+ MCs seems to be activated. Is this pertinent to all the samples? Or is it phase
specific phenomenon?
 
Discussion:
Page 10, “We found that the   of tryptase and chymase mRNA  ”, should beconcentrations
replaced with “levels”
 
The statement “As tryptase and chymase are constitutively expressed by MCs (Pejler  ., 2007),et al
it is unsurprising they may remain unchanged if cell numbers are fairly constant.” Need to be
updated with reference to activated MC releasing the tryptases to the extracellular compartment,
but the extracellular compartment is part of the whole endometrial lysate that has been examined
so overall levels are not expected to change anyway.
 
The reference to some other papers that agree and disagree with their work (mentioned above),
authors may also acknowledge the small sample size as a limitation of their study.
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We thank Dr Kamal for her comments on our paper which we have edited to address some of her
concerns.
Specific responses:
We have now referenced the small study by Mori   (1997) in the Introduction and the study byet al
Engemise   in the Discussion.et al
We have changed the text of the Introduction so that the abbreviations for TPSAB1 and CMA1 are
introduced during the first mention of their importance in defining the mast cell phenotype.
Methods.
The text describing the samples has been changed to highlight the patient information provided in
Suppl Table 1 and clarify that although 46 patients were recruited during this study their samples
were split between RNA (n=29) and fixation for immunostaining (n=26).
Analysis methods for RTPCR data: Although the delta delta CT method is one of the most popular
it is based on comparable amplification efficiencies of the endogenous control and gene of interest.
As determined by the standard curves the efficiencies of the TPSAB1 and CMA1 were not suitable
for analysis by this method and therefore a more appropriate method was the relative standard
curve method. The text in M&M has been revised to make this clearer.
See: Bustin SA, Benes V, Garson JA etal, the MIQE guidelines: Minimum Information for
Publication of Quantitative Real-Time PCR experiments, Clinical Chemistry 55:4 611-622 (2009)
These methods are also described in detail in Applied Biosystems manual online
http://www6.appliedbiosystems.com/support/tutorials/pdf/performing_rq_gene_exp_rtpcr.pdf
The tonsil sample was chosen as a positive control as this tissue has mast cells which contain
tryptase and chymase, the RNA sample was purchased from a commercial supplier and we chose
this tissue because we were able to access fixed material from our hospital to use for control
experiments to validate the antibodies.
For dual immunostaining primary antibodies were applied to sections overnight (16h) and
incubated in a fridge - secondary antibodies were applied for 1h at room temperature. This is a
standard method used in our laboratory and in our hands it leads to lower rates of non-specific
background staining than application of primary antibody at room temperature. We did not quantify
the fluorescent staining.
Results.
The limitations on the amount of individual fixed samples meant that not all of the fixed samples
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 The limitations on the amount of individual fixed samples meant that not all of the fixed samples
(n=20) were stained with all antibodies and this is reflected in the numbers stated in the figure
legends.
MCs were considered as ERbeta positive only if the entire nucleus was identified in the section (as
highlighted with white arrowheads). In this study the low number of chymase only MCs meant we
were not able to conduct a comprehensive staining for ERbeta.
In the summary Table 1 we decided to combine the results from the functional and basal layers
because the mast cells were very rare in the former and we wanted to provide an overview to
complement the more comprehensive data shown in the individual photographs.
Our interpretation of the data related to GR positive cells (as illustrated in Figure 3, 6 panels) is that
the tryptase positive mast cells that were GR+ appeared to be in resting state i.e. the tryptase
appeared to be confined to the cytoplasmic area around the nucleus.
Discussion.
We used a standard curve method so 'concentration' is more appropriate than 'levels' which is a
common term when the delta CT method is used.
We have changed the text to make it clearer that this paragraph is discussing mRNAs and hence
protein release is not relevant to the argument about constitutive expression. 
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This article examines in detail the phenotypes of mast cells in the uterus – depending on their
tryptase/chymase content and their steroid hormone receptor status. The work is solid, and well
presented. The methods are well described so that others can validate the data. While tryptase/chymase
phenotypes have previously been described across the menstrual cycle (referenced), the information
regarding a tryptase-/chymase+ phenotype is new, as is the steroid receptor phenotypeof
ERβ+/GR+/ERα-/PR-  in tryptase positive cells. Where the data particularly varies from that previously
published is in the activation status of the mast cells. This variation could be explained by different fixation
protocols or different antibodies. Activation is very important as mast cells are only functionally relevant
following this release of the potent molecular contents of their granules.
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